Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Debt (2019 - 2025)

Pulmonx has reported Total Debt over the past 7 years, most recently at $37.1 million for Q4 2025.

  • Quarterly Total Debt changed 0.22% to $37.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.1 million through Dec 2025, changed 0.22% year-over-year, with the annual reading at $37.1 million for FY2025, 0.22% changed from the prior year.
  • Total Debt was $37.1 million for Q4 2025 at Pulmonx, roughly flat from $37.1 million in the prior quarter.
  • Over five years, Total Debt peaked at $37.3 million in Q1 2023 and troughed at $270000.0 in Q4 2021.
  • The 5-year median for Total Debt is $37.1 million (2025), against an average of $26.2 million.
  • Year-over-year, Total Debt crashed 52.13% in 2021 and then soared 6316.3% in 2022.
  • A 5-year view of Total Debt shows it stood at $270000.0 in 2021, then soared by 6316.3% to $17.3 million in 2022, then soared by 114.98% to $37.2 million in 2023, then decreased by 0.18% to $37.2 million in 2024, then decreased by 0.22% to $37.1 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Total Debt are $37.1 million (Q4 2025), $37.1 million (Q3 2025), and $37.1 million (Q2 2025).